Neoadjuvant Nivolumab-Ipilimumab Could Be New Standard Care in dMMR Colon Cancer
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age.
Postdiagnosis intake of unprocessed red meat, processed meat not linked with recurrence or mortality risk in patients with stage III colon cancer.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
The association was observed with colon cancer but not rectal cancer.
Colorectal cancer rates have been rising in younger people for years, and screenings are now recommended to begin at a younger age. How much and why have rates been increasing, and what preventive steps can you teach these patients to lessen their risk?
Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.
In response to the rising incidence of CRC in patients younger than 50 years, the USPSTF proposes CRC screening at 45 years as the new clinical standard.
Danish investigators conducted a cohort study to assess the impact of low-dose aspirin on lower gastrointestinal bleeding, colorectal bleeding, and colorectal polyps.
Some guidelines suggest colorectal cancer (CRC) screening by age 50 for African Americans, but data on screening uptake and yield among this population is limited.